In a pioneering investigation, an oral DNA vaccine targeting FAP targets was shown to drastically decrease primary tumor cell proliferation and neovascularization, considerably boost intra-tumor medication absorption, and minimize metastasis in colon and breast cancers by killing tumor-associated fibroblasts (Loeffler et al., 2006). The gene discussed is FAP; the disease is breast cancer.